Latest S-1 registration statements
ECD Automotive Design, a custom luxury car builder, reported substantial net losses and a working capital deficit, raising going concern doubts, even as it pursues new financing, expands product lines, and undergoes key management changes.
NASDAQ
ENDRA Life Sciences Inc. is launching a public offering of common stock and warrants to raise approximately $118 million, primarily to fund a new treasury strategy focused on holding bitcoin and other cryptocurrencies, while continuing to develop its TAEUS medical technology.
NASDAQ
reAlpha Tech Corp. is conducting a best-efforts public offering of up to 16.38 million shares and warrants to raise approximately $3.5 million, while facing Nasdaq delisting notices and transitioning its business from short-term rentals to an AI-powered homebuying platform.
Functional Brands Inc., a nutraceutical and hemp-derived product manufacturer, is pursuing a direct listing on Nasdaq while grappling with recurring losses, negative cash flows, and a significant accumulated deficit, prompting an auditor's going concern warning.
AMEX
AIM ImmunoTech Inc. has filed an amended registration statement for a public offering of up to $10 million in units, seeking to raise capital while facing significant financial challenges including negative stockholders' equity and a risk of delisting from the NYSE American.
NASDAQ
Harvard Ave Acquisition Corporation, a Cayman Islands-incorporated blank check company, filed an amended S-1 registration statement for its initial public offering of 18 million units at $10.00 each, emphasizing its search for a business combination while disclosing substantial potential dilution for public shareholders and risks associated with its international management and sponsor structure.
NYSE
Accelerant Holdings, a specialty insurance marketplace, is set to launch its initial public offering on the NYSE, showcasing robust premium growth and a recent shift to profitability driven by its data-driven risk exchange model.
NASDAQ
CARL
Carlsmed, INCCarlsmed, a medical technology company specializing in AI-enabled personalized spine surgery, is pursuing an initial public offering of 6.7 million shares, aiming to raise approximately $88.3 million to fuel commercialization and R&D, particularly for its planned 2026 cervical spine fusion market entry.
NASDAQ
Solarius Capital Acquisition Corp., a newly formed blank check company, filed an amended S-1 registration statement for its $150 million initial public offering, aiming to acquire businesses in the asset management, wealth management, and financial services sectors.
NASDAQ
reAlpha Tech Corp. is seeking to raise up to $3.52 million through a public offering of common stock and warrants to fund operations, while facing Nasdaq delisting warnings, a substantial accumulated deficit, and an independent auditor's going concern doubt.
OID
GBUX
Givbux, INCGivBux, Inc. has filed an S-1 registration statement to register shares for resale from a recent convertible note and warrant financing of up to $11.11 million, as the company continues to report substantial net losses and faces a going concern doubt.
NASDAQ
ARAI
Arrive Ai INCArrive AI Inc., a developmental technology company focused on smart mailboxes for autonomous last-mile delivery, has filed an S-1/A registration statement to allow for the resale of up to 8,125,779 shares, outlining its strategic product roadmap, financial performance marked by ongoing losses, and significant capital raising efforts.
NASDAQ
A biopharmaceutical company is registering a significant resale of common stock by existing holders, while grappling with Nasdaq non-compliance issues and a 'going concern' audit opinion, signaling substantial financial challenges.
AMEX
TGEN
Tecogen INCTecogen Inc. has filed an S-1 registration statement to offer 2.67 million shares of common stock, aiming to raise capital for its strategic expansion into the artificial intelligence data center market and other growth initiatives, despite an operating history of losses and identified material weaknesses in internal controls.
NASDAQ
Duos Technologies Group, Inc. announced a substantial 363% increase in first-quarter 2025 revenues, primarily due to a new Asset Management Agreement in the power generation sector, even as its core rail technology segment faced significant project delays.
OTC.Pink
Dror Ortho-Design, Inc., a development-stage company, filed an amended S-1 registration statement to offer up to 2,020,203 shares of common stock and warrants, aiming to raise approximately $8.9 million for working capital and general corporate purposes, while facing significant operating losses and a going concern warning.
NASDAQ
XELB
Xcel Brands, INCXcel Brands, Inc. is offering up to 1.38 million shares of common stock and pre-funded warrants at $1.81 per share to raise approximately $1.9 million in net proceeds for brand development, working capital, and debt management, following a recent reverse stock split and significant debt restructuring.
NASDAQ
Citius Oncology, Inc. is offering up to 5,319,149 shares of common stock and accompanying warrants to raise an estimated $13.65 million to fund the commercialization of its FDA-approved oncology drug LYMPHIR, despite significant financial challenges and a going concern warning.
Global Interactive Technologies, Inc. has filed an S-1 registration statement for a public offering of common stock and warrants to raise capital, while facing significant financial losses, an auditor's going concern warning, and an ongoing appeal against a Korean securities fine.
NASDAQ
Elite Express Holding Inc., a California-based last-mile delivery service provider, has filed an S-1/A registration statement for its initial public offering of 4,000,000 shares of Class A common stock at an estimated price of $4.00 per share, aiming to raise approximately $14 million for strategic acquisitions, fleet upgrades, and technology development.
OTC.Pink
Scientific Industries, Inc. filed an S-1/A registration statement for the resale of up to 3.1 million shares of common stock by selling stockholders, emphasizing its strategic shift towards the Bioprocessing Systems segment despite ongoing net losses and a stated need for additional funding to continue as a going concern.
NASDAQ
XCUR
Exicure, INCExicure, Inc. is undergoing a significant strategic shift, divesting historical biotechnology assets to focus on new ventures including a blood cancer clinical trial and Korean entertainment and renewable energy businesses, while actively raising capital to address substantial doubt about its ability to continue as a going concern.
NYSE
S-1/A: NIQ Global Intelligence Files for IPO, Highlights Strong Growth and AI-Powered Transformation
NIQ Global Intelligence plc, a leading consumer intelligence company, filed an S-1/A registration statement for its initial public offering of 50 million ordinary shares, aiming to repay debt and continue its strategic growth initiatives driven by AI and expanded market coverage.
NYSE
McGraw Hill, Inc. has filed an amendment to its S-1 registration statement, detailing its initial public offering of 24.39 million shares, a strategic focus on digital learning solutions, and plans to use IPO proceeds to significantly reduce its substantial debt.
PAPA
Papa Medical INCPapa Medical Inc., a pioneering provider of end-to-end Hemp dosing solutions, has filed an amended S-1 registration statement for its initial public offering of 1,250,000 shares at an estimated price of US$4 per share, aiming to raise US$5 million before expenses for R&D, plant upgrades, and sales expansion.
NASDAQ
Citius Oncology, Inc. has filed an S-1 registration statement to raise up to $15 million through a public offering of common stock and warrants, aiming to fund the commercialization of its recently FDA-approved oncology drug LYMPHIR, while facing substantial doubt about its ability to continue as a going concern.
NASDAQ
ONMD
Onemednet CORPS-1/A: Healthcare Software Firm Faces Delisting Threat Amidst Deepening Losses and Extensive Dilution
A healthcare software company is seeking to register millions of shares for public and secondary offerings while grappling with significant financial losses, a going concern warning, and multiple Nasdaq listing deficiencies.
OQB
RYES
Rise Gold CORPA Nevada-based mineral exploration company is registering shares for resale by existing stockholders while navigating significant financial losses and regulatory challenges for its primary gold project in California.
AMEX
Picard Medical, Inc., developer of the only FDA-approved total artificial heart, is seeking to raise $15.4 million in its initial public offering on the NYSE American, despite a history of substantial net losses and an auditor's warning about its ability to continue as a going concern.
NASDAQ
Trailblazer Acquisition Corp., a newly formed blank check company, files an S-1 registration statement for a $200 million initial public offering to seek a business combination in media, tech, sports, or retail.